NLS Drug development

The high cost and uncertain outcomes of developing new drugs has taken a toll on research over the past several years.  Few companies can take the hit of investing hundreds of thousands of dollars in research and testing, only to see dangerous side effects emerge during the final stages, human clinical trials. The pursuit of […]

Much effort is being made to develop new medicines for diabetes and recent findings indicate the potential for new and improved pharmaceuticals. Diabetes is one of the largest global diseases and there is a huge unmet need for efficient medicines. The firsthand medication for type 2 diabetes has long been the oral drug metformin. Glitazones […]

The estimated average cost of developing an approved new drug has more than doubled to more than $2.5 billion from a 2003 estimate by Tufts University. But critics questioned the figure and noted the school’s strong financial ties to the pharmaceutical industry.  The Tufts Center for the Study of Drug Development, located in Boston, in […]

Here’s a sample of some of the latest Nordic medtech and pharma progress in cancer treatments. Cancer is perhaps the hottest area within pharmaceutical research in the world right now. According to the U.S. pharmaceutical industry association PhRMA, there are nearly 1,000 new substances being developed in commercial clinical cancer research run by pharmaceutical companies. […]